edoc
Improving Our Understanding of Infants With Substance Exposure and Neonatal Abstinence Syndrome (NAS) [Presentation Slides] (CFRP Webinar, October 31, 2017).
National Center for Fatality Review and Prevention.
Presentation
74 slides
Copyright
Published: 2017
National Center for Fatality Review and Prevention
Michigan Public Health Institute
2395 Jolly Road
Suite 120
Okemos, MI 48864
Tel: 517-324-8375
Fax: 517-324-7365
info@ncfrp.org
Available From:https://www.ncfrp.org/
Download: https://www.ncfrp.org/wp-content/uploads/NCRPCD-Docs/NCFRP-Webinar-103107-Substance-Use-and-NAS-Part1-slides.pdf
This slide presentation accompanied a webinar that discussed opioid disorders and the difference between neonatal abstinence syndrome (NAS) and substance exposure, factors associated with substance use during pregnancy, best practices for collaboration and Plans of Safe Care, and strategies for fatality review teams for addressing the needs of families affected by substance use disorders. Slides present information on: the number of infants affected by prenatal exposure by type of substance and infant disorder; the increase in the number of children in out of home care from 2012-2015; the prevalence of parental alcohol or other drug use as a contributing factor for reason for removal from 2000-2015; data monitoring challenges; the rise of kinship care for children with parental alcohol and drug use as a removal factor from 34% in 2008 to over 40% in 2014; the short-term and long-term effects of substance exposure on children; the increase in the rates of NAS from 2000-2013; symptoms of NAS; the safety of medication assisted treatment for treating opioid use disorders in pregnant women; evidence-based approaches to NAS treatment; the benefits of family centered treatment and collaborative practice; technical assistance to States for improving practices and policies; services that support families; barriers to screening; signs of family recovery; changes made to CAPTA by the passage of the Comprehensive Addiction and Recovery Act of 2016; and key components of a CAPTA Plan of Safe Care.
Keywords:
NEONATAL ABSTINENCE SYNDROME; ADDICTED INFANTS; PRENATAL CHILD ABUSE; DRUG WITHDRAWAL SYMPTOMS; PRENATAL CARE; PRENATAL DRUG EXPOSURE; SUBSTANCE ABUSING MOTHERS; OPIOID ADDICTION; DRUG THERAPY; REMOVING CHILD FROM HOME; EVIDENCE BASED PRACTICE; INTERAGENCY COLLABORATION; FAMILY CENTERED SERVICES